119 related articles for article (PubMed ID: 36456179)
1. Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters.
Young RP; Ward RC; Scott RJ; Gamble GD; Silvestri G
Thorax; 2023 Jul; 78(7):690-697. PubMed ID: 36456179
[TBL] [Abstract][Full Text] [Related]
2. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.
Hopkins RJ; Duan F; Chiles C; Greco EM; Gamble GD; Aberle D; Young RP
Ann Am Thorac Soc; 2017 Mar; 14(3):392-402. PubMed ID: 28076701
[TBL] [Abstract][Full Text] [Related]
3. Should we be screening for COPD? - looking through the lens of lung cancer screening.
Young RP; Scott RJ
Expert Rev Respir Med; 2023; 17(9):753-771. PubMed ID: 37728077
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T
BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926
[TBL] [Abstract][Full Text] [Related]
5. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA
Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
Kaise T; Sakihara E; Tamaki K; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R
Int J Chron Obstruct Pulmon Dis; 2021; 16():2665-2675. PubMed ID: 34588775
[TBL] [Abstract][Full Text] [Related]
7. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.
Weiss G; Steinacher I; Lamprecht B; Kaiser B; Mikes R; Sator L; Hartl S; Wagner H; Studnicka M
NPJ Prim Care Respir Med; 2017 Jan; 27(1):4. PubMed ID: 28127061
[TBL] [Abstract][Full Text] [Related]
9. Airflow limitation classified with the fixed ratio or the lower limit of normal and cause-specific mortality - A prospective study.
Torén K; Andersson M; Olin AC; Blanc PD; Järvholm B
Respir Med; 2018 Nov; 144():36-41. PubMed ID: 30366582
[TBL] [Abstract][Full Text] [Related]
10. Association of pectoralis muscle area on computed tomography with airflow limitation severity and respiratory outcomes in COPD: A population-based prospective cohort study.
Zhou K; Wu F; Zhao N; Zheng Y; Deng Z; Yang H; Wen X; Xiao S; Yang C; Chen S; Zhou Y; Ran P;
Pulmonology; 2023 Mar; ():. PubMed ID: 36907812
[TBL] [Abstract][Full Text] [Related]
11. Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.
Tejero E; Prats E; Casitas R; Galera R; Pardo P; Gavilán A; Martínez-Cerón E; Cubillos-Zapata C; Del Peso L; García-Río F
Am J Respir Crit Care Med; 2017 Aug; 196(3):298-305. PubMed ID: 28306326
[TBL] [Abstract][Full Text] [Related]
12. Asthma, airflow limitation and mortality risk in the general population.
Huang S; Vasquez MM; Halonen M; Martinez FD; Guerra S
Eur Respir J; 2015 Feb; 45(2):338-46. PubMed ID: 25323227
[TBL] [Abstract][Full Text] [Related]
13. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial.
Labaki WW; Xia M; Murray S; Hatt CR; Al-Abcha A; Ferrera MC; Meldrum CA; Keith LA; Galbán CJ; Arenberg DA; Curtis JL; Martinez FJ; Kazerooni EA; Han MK
Chest; 2021 May; 159(5):1812-1820. PubMed ID: 33326807
[TBL] [Abstract][Full Text] [Related]
15. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of airflow limitation on medical check-up in Japanese subjects.
Omori H; Nonami Y; Mihara S; Marubayashi T; Morimoto Y; Aizawa H
J UOEH; 2007 Sep; 29(3):209-19. PubMed ID: 17900001
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of the Uplift Clinical Trial Using Age-Appropriate Spirometric Criteria.
Vaz Fragoso CA; Leo-Summers LS; Gill TM; McAvay GJ
Chest; 2020 Aug; 158(2):539-549. PubMed ID: 32278783
[TBL] [Abstract][Full Text] [Related]
19. Lung Function Abnormalities in Smokers with Ischemic Heart Disease.
Franssen FM; Soriano JB; Roche N; Bloomfield PH; Brusselle G; Fabbri LM; García-Rio F; Kearney MT; Kwon N; Lundbäck B; Rabe KF; Raillard A; Muellerova H; Cockcroft JR
Am J Respir Crit Care Med; 2016 Sep; 194(5):568-76. PubMed ID: 27442601
[TBL] [Abstract][Full Text] [Related]
20. The potential impact of chronic obstructive pulmonary disease in lung cancer screening: implications for the screening clinic.
Young RP; Hopkins R
Expert Rev Respir Med; 2019 Aug; 13(8):699-707. PubMed ID: 31274043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
